1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Netherlands >
  5. Galapagos Acquires CellPoint

M&A Deal Summary

Galapagos Acquires CellPoint

On June 22, 2022, Galapagos acquired information technology company CellPoint for 125M USD

Acquisition Highlights
  • This is Galapagos’ 1st transaction in the Information Technology sector.
  • This is Galapagos’ 2nd largest (disclosed) transaction.
  • This is Galapagos’ 1st transaction in the Netherlands.

M&A Deal Summary
Date 2022-06-22
Target CellPoint
Sector Information Technology
Buyer(s) Galapagos
Deal Type Add-on Acquisition
Deal Value 125M USD

Target

CellPoint

Oegstgeest, Netherlands
CellPoint is a developer of proprietary xCellit real-time monitoring software system, generating clinical data to validate decentralized manufacturing supply model with CD19 CAR-T for rrNHL/rrCLL. CellPoint is based in Oegstgeest, Netherlands.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Galapagos

Mechelen, Belgium
Category Company
Founded 1999
Sector Life Science
Employees683
Revenue 276M EUR (2024)
DESCRIPTION

Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.

DEAL STATS #
Overall 9 of 9
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Netherlands M&A 1 of 1
Year: 2022 M&A 2 of 2
Size (of disclosed) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-22 AboundBio

Pittsburgh, Pennsylvania, United States

AboundBio is a privately held biotechnology company generate novel antibody-based biological therapeutics for cancers of unmet medical need. AboundBio is based in Pittsburgh, Pennsylvania.

Buy $14M
Mergr

Solution for

Product

Company

Legal